GD Q1 2026 Earnings Strong Earnings Beat Driven by Aerospace and Defense Momentum Ovid Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Cash Discipline CGAU Q1 2026 Earnings EPS Misses Estimates Amid Mixed Gold Market Conditions ADIL Q1 2026 Earnings Narrowed Loss Beats Estimates but Market Remains Cautious SOWG Q3 2025 Earnings Significant EPS Miss Highlights Operational Challenges